9th Market Access, Pricing, & Reimbursement Global Congress
2nd Real-world Evidence World Congress Europe
Sponsored Spotlight Sessions
European Collaboration on Health Technology Assessment – the New Road to Access
Elvira Müller, PhD
|VP HTA and Evidence Development
Overview and key aspects | Status and timeline | EU joint HTA and national submissions | Challenges and implications
Leveraging Real-World Data during the COVID-19 Pandemic: The Dawn of a New Era for Real-World Evidence – Opportunities and Challenges
Stephane Read
|Senior Epidemiologist
Robust RWE generation to accelerate drug approval and inform clinical practice during a rapidly evolving pandemic | COVID-19 and the wide-ranging role of RWE in informing decision making: From disease monitoring to treatment effectiveness | Methodological considerations and cautionary tales of RWE generation in COVID-19 | Best practices and lessons learned for effectively utilizing RWD/RWE in future pandemics